We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Commission on Human Medicines (CHM) has concluded that the risk of vCJD cases arising from the use of UK plasma for the manufacture of immunoglobulin medicinal products would be negligible.
Report from SaBTO's Paediatric Components Working Group looking at whether scientific evidence supports updating specific vCJD risk reduction measures.
This order provides measures to ensure that charging for transmission losses takes account of generators’ locations.
How to register your vehicle and the cost - new registrations, kit cars, rebuilds, radically altered vehicles, old and classic vehicles, vehicle identification numbers, Q plates
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Leading scientists at the independent Commission on Human Medicines (CHM) have confirmed that albumin, a critically important medicine for the NHS, can now be safely derived from UK plasma donors.
The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD.
Paper prepared by University of Warwick on the Delta (B.1.617.2) variant of concern.
This review looked into the way that the offshore transmission network is designed and delivered. It concluded in May 2023, and the organisations involved, including the Department for Energy Security and Net Zero, are now implementing its findings to deliver...
The symptoms, means of transmission, best means of prevention and treatment of RSV.
This paper, including the emerging findings of the appendix prevalence study, was considered at the meeting of the Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Assessment Sub-Group on 14 July 2011.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
These reviews aim to identify and examine evidence on the risk of transmission from handling the bodies of deceased persons with COVID-19.
These rapid reviews aim to identify and examine evidence on transmission of COVID-19 in different settings, and interventions to reduce COVID-19 transmission.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).